Hypoglycemia, its implications in clinical practice, and possible ways to prevent it

被引：5
作者：
Maffioli, Pamela [1 ,2 ]
Derosa, Giuseppe [1 ,2 ,3 ]
机构：
[1] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy
[2] Fdn IRCCS Policlin S Matteo, Pavia, Italy
[3] Univ Pavia, Ctr Study Endocrine Metab Pathophysiol & Clin Res, I-27100 Pavia, Italy
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2014年 / 30卷 / 05期
关键词：
DPP-4; inhibitors; Hypoglycemia; Sulfonylureas Type 2 diabetes mellitus; TYPE-2; DIABETES-MELLITUS; ADD-ON THERAPY; CARDIAC REPOLARIZATION; METFORMIN; SAXAGLIPTIN; GLIPIZIDE; GLIBENCLAMIDE; PIOGLITAZONE; ASSOCIATION; MECHANISMS;
D O I：
10.1185/03007995.2014.890096
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：771 / 773
页数：3
相关论文
共 28 条
  • [1] Mechanisms of the glycaemic effects of sulfonylureas
    Ashcroft, FM
    [J]. HORMONE AND METABOLIC RESEARCH, 1996, 28 (09) : 456 - 463
  • [2] Characteristics and outcomes of older patients presenting to the emergency department after a fall: a retrospective analysis
    Bell, AJ
    Talbot-Stern, JK
    Hennessy, A
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (04) : 179 - 182
  • [3] Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs
    Bron, Morgan
    Marynchenko, Maryna
    Yang, Hongbo
    Yu, Andrew P.
    Wu, Eric Q.
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (01) : 124 - 132
  • [4] A comparison between sitagliptin or glibenclamide in addition to metformin plus pioglitazone on glycaemic control and -cell function: the triple oral therapy
    Derosa, G.
    Cicero, A. F. G.
    Franzetti, I. G.
    Querci, F.
    Carbone, A.
    Piccinni, M. N.
    D'Angelo, A.
    Fogari, E.
    Maffioli, P.
    [J]. DIABETIC MEDICINE, 2013, 30 (07) : 846 - 854
  • [5] Pioglitazone Compared to Glibenclamide on Lipid Profile and Inflammation Markers in Type 2 Diabetic Patients During an Oral Fat Load
    Derosa, G.
    Cicero, A. F. G.
    Fogari, E.
    D'Angelo, A.
    Bianchi, L.
    Maffioli, P.
    [J]. HORMONE AND METABOLIC RESEARCH, 2011, 43 (07) : 505 - 512
  • [6] Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience
    Derosa, Giuseppe
    Maffioli, Pamela
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (04) : 350 - 364
  • [7] Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524
  • [8] Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial
    Goeke, Burkhard
    Gallwitz, Baptist
    Eriksson, Johan G.
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (04) : 307 - 316
  • [9] Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial
    Goke, B.
    Gallwitz, B.
    Eriksson, J.
    Hellqvist, A.
    Gause-Nilsson, I.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (12) : 1619 - 1631
  • [10] Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
    Heller, S. R.
    Choudhary, P.
    Davies, C.
    Emery, C.
    Campbell, M. J.
    Freeman, J.
    Amiel, S. A.
    Malik, R.
    Frier, B. M.
    Allen, K. V.
    Zammitt, N. N.
    Macleod, K.
    Lonnen, K. F.
    Kerr, D.
    Richardson, T.
    Hunter, S.
    Mclaughlin, D.
    [J]. DIABETOLOGIA, 2007, 50 (06) : 1140 - 1147
123